Global Phenylketonuria Market Size To Grow USD 1121.01 Billion By 2030 | CAGR of 6.2%
According to a research report published by Spherical Insights & Consulting, Global Phenylketonuria Market Size is To Grow from USD 610.3 Million in 2022 to USD 1121.01 Million by 2032, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Phenylketonuria (PKU), a rare hereditary condition, results in the overproduction of the amino acid phenylalanine. This amino acid is present in all proteins and certain artificial sweeteners. The body’s phenylalanine hydroxylase enzyme produces the non-essential amino acid tyrosine, vital for neurotransmitter production such as dopamine, norepinephrine, and epinephrine. A mutation in the PAH gene, encoding the phenylalanine hydroxylase enzyme, can lead to PKU. The global phenylketonuria market encompasses diagnostic procedures, treatments, and dietary supplements for PKU patients.
Increasing awareness among medical professionals and the public, coupled with government support for novel treatments, propels the phenylketonuria market’s growth. Innovations include gene therapy, pharmacological therapies, and enzyme replacement therapy. However, the high cost of PKU treatments may hinder access, especially in low- and middle-income nations. Clinical trials face challenges due to the disorder’s frequency and limited availability of specialized medical meals, potentially delaying therapy development.
COVID-19 has impacted the PKU market, causing disruptions in healthcare services, delayed diagnosis, and treatment for individuals with PKU. Economic strains may affect affordability of specialized medical foods, influencing treatment adherence. The pandemic has accelerated telemedicine adoption, providing remote care opportunities that could benefit PKU patients.
The nutrition supplements segment dominates the market, offering specialized medical foods and supplements tailored to reduce phenylalanine intake. These include infant formulae, beverages, and snack bars rich in nutrients but low in phenylalanine. Hospital pharmacies hold the largest market share among end-users, driven by infrastructure capacity and patient preference for medication reviews by doctors.
The global phenylketonuria market, categorized by type, includes hyperphenylalaninemia, mild PKU, moderate and variant, classic PKU, and others.
Get a free sample PDF: https://www.sphericalinsights.com/request-sample/1704
List of Key Companies
- Daiichi Sankyo Company Limited
- Cambrooke Therapeutics
- American Gene Technologies International, Inc.
- Dimension Therapeutics, Inc.
- Synthetic Biologics, Inc.
- BioMarin Pharmaceutical, Inc.
- Erytech Pharma SA
- Danone Nutricia
- Censa Pharmaceuticals
- Homology Medicines, Inc.
- SOM Innovation Biotech SL
- Mayo Foundation for Medical Education and Research
- Rubius Therapeutics, Inc.
Buy Now full Report: https://www.sphericalinsights.com/checkout/1704
Recent Development
- In July 2022, Preclinical evidence for Jnana Therapeutics’ flagship program, which could be the first oral strategy of its kind to treat PKU, has been reported. At the Vancouver, Washington, 2022 National PKU Alliance Conference, data has been presented.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the Global Phenylketonuria Market based on the below mentioned segments:
Global Phenylketonuria Market, By Product Type
- Drugs
- Nutrition Supplements
- Others
Global Phenylketonuria Market, By Type
- Hyperphenylalaninemia
- Mild PKU
- Moderate and Variant
- Classic PKU
Global Phenylketonuria Market, By End Users
- Hospital Pharmacies
- Retail Pharmacies
- Others
By region:
- North America (US, Canada, Mexico)
- Europe (Germany, Uk, France, Italy, Spain, Russia, Rest of Europe,)
- Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, and Rest of Middle East & Africa)
Competitive analysis:
The competitive analysis section of the Global Phenylketonuria Market research report provides a detailed study of the competitive landscape within the market. It aims to identify and assess key market players, their strategies, and their impact on overall market dynamics. Each company’s profile provides insight into its business profile, product portfolio, geographic presence, and recent developments. This information helps stakeholders to gain a comprehensive understanding of market participants and their capabilities.
In addition, competitive analysis examines the market share held by each major player and assesses their position within the market. Assessing relative market strength considers factors such as revenue, market capitalization, and market share growth over time. By understanding the distribution of market shares, industry participants can identify key players and their market power.
Browse key industry insights spread across 200 pages with 146 market data tables and figures & charts from the report on the “Global Phenylketonuria Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Drugs, Nutrition Supplements, Others), By Type (Hyperphenylalaninemia, Mild PKU, Moderate and Variant, Classic PKU), By End Users (Hospital Pharmacies, Online Pharmacies, Drug Stores, Pediatric Clinics, & Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022– 2032.”
Access full report: https://www.sphericalinsights.com/reports/phenylketonuria-market
The Global Phenylketonuria Market research report aims to answer the following key questions:
- What are the main products/services offered in the market and how are they evolving to meet changing consumer demands?
- What are the key technological advances and innovations impacting the market and how will they affect the competitive landscape?
- What are the key distribution channels and marketing strategies market players employ to effectively reach their target audience?
- What are the price trends in the market, and how do prices change across different product segments and geographies?
- How will changing demographic patterns, such as age groups and income levels, affect consumer behavior and market demand?
- What are the key cost factors and factors that influence the profitability of companies in the Global Phenylketonuria Market?
- How will sustainability and environmental considerations affect consumer preferences and market growth in this sector?
- What are the investment opportunities and challenges for new entrants and investors looking to enter the market?
- How do government policies and regulations impact market dynamics and shape industry strategies?
- What are the current supply chain trends and challenges in the market, and how do they affect product availability and pricing?
- What are the levels of customer satisfaction and loyalty within the market, and how do market participants differentiate in terms of service quality?
About Newness Insights & Consulting
Newness Insights & Consulting is a dynamic market research and consulting company specializing in delivering valuable market research studies, precise quantitative forecasting, and insightful trend analysis tailored to empower decision-makers. Our forward-looking insights are meticulously crafted to enhance ROI and drive success.
We serve a diverse range of industries, including the financial sector, industrial enterprises, government organizations, universities, non-profit entities, and corporations. Our core mission revolves around collaborating with businesses to not only attain their strategic objectives but also sustain continuous improvement.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us